Concepts (298)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Islets of Langerhans | 24 | 2020 | 76 | 5.380 |
Why?
|
| Alginates | 30 | 2020 | 52 | 5.190 |
Why?
|
| Islets of Langerhans Transplantation | 19 | 2017 | 46 | 4.800 |
Why?
|
| Cells, Immobilized | 9 | 2017 | 22 | 3.260 |
Why?
|
| Drug Compounding | 11 | 2017 | 36 | 2.200 |
Why?
|
| Tissue Engineering | 13 | 2020 | 659 | 1.840 |
Why?
|
| Cell Separation | 4 | 2017 | 90 | 1.490 |
Why?
|
| Capsules | 7 | 2017 | 14 | 1.490 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2017 | 265 | 1.440 |
Why?
|
| Ovary | 3 | 2017 | 59 | 1.400 |
Why?
|
| Microspheres | 16 | 2020 | 44 | 1.350 |
Why?
|
| Pancreas | 8 | 2020 | 103 | 1.340 |
Why?
|
| Omentum | 7 | 2017 | 25 | 1.330 |
Why?
|
| Animals | 44 | 2020 | 7599 | 1.310 |
Why?
|
| Granulosa Cells | 3 | 2019 | 11 | 1.280 |
Why?
|
| Hexuronic Acids | 22 | 2017 | 31 | 1.260 |
Why?
|
| Glucuronic Acid | 22 | 2017 | 31 | 1.260 |
Why?
|
| Hormone Replacement Therapy | 3 | 2019 | 89 | 1.220 |
Why?
|
| Antioxidants | 7 | 2006 | 116 | 1.090 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2020 | 182 | 1.080 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2017 | 58 | 1.020 |
Why?
|
| Oxygen | 2 | 2017 | 144 | 0.990 |
Why?
|
| Pancreas, Artificial | 3 | 2013 | 4 | 0.970 |
Why?
|
| Hydrogels | 4 | 2020 | 126 | 0.910 |
Why?
|
| Biocompatible Materials | 7 | 2020 | 233 | 0.900 |
Why?
|
| Theca Cells | 3 | 2019 | 9 | 0.880 |
Why?
|
| Peptides | 5 | 2017 | 126 | 0.870 |
Why?
|
| Cell Culture Techniques | 4 | 2017 | 172 | 0.830 |
Why?
|
| Regenerative Medicine | 4 | 2013 | 202 | 0.790 |
Why?
|
| Tissue Scaffolds | 7 | 2020 | 421 | 0.760 |
Why?
|
| Probiotics | 2 | 2020 | 9 | 0.760 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2020 | 30 | 0.750 |
Why?
|
| Bioengineering | 3 | 2020 | 68 | 0.730 |
Why?
|
| Drug Delivery Systems | 5 | 2019 | 105 | 0.730 |
Why?
|
| Insulin-Secreting Cells | 3 | 2020 | 53 | 0.690 |
Why?
|
| Estrogens | 2 | 2019 | 169 | 0.690 |
Why?
|
| Osmotic Pressure | 3 | 2018 | 10 | 0.680 |
Why?
|
| Neovascularization, Physiologic | 7 | 2017 | 111 | 0.630 |
Why?
|
| Cell Survival | 8 | 2020 | 281 | 0.620 |
Why?
|
| Cross-Linking Reagents | 3 | 2017 | 16 | 0.610 |
Why?
|
| Polylysine | 2 | 2017 | 5 | 0.600 |
Why?
|
| Polymers | 3 | 2019 | 66 | 0.560 |
Why?
|
| Stress, Mechanical | 2 | 2017 | 96 | 0.560 |
Why?
|
| Fibroblast Growth Factor 1 | 7 | 2014 | 9 | 0.550 |
Why?
|
| Coculture Techniques | 3 | 2017 | 80 | 0.540 |
Why?
|
| Bioartificial Organs | 1 | 2017 | 25 | 0.540 |
Why?
|
| Cell Transplantation | 4 | 2017 | 64 | 0.540 |
Why?
|
| Carbonates | 1 | 2017 | 3 | 0.510 |
Why?
|
| Humans | 34 | 2020 | 32968 | 0.510 |
Why?
|
| Diabetes Mellitus | 2 | 2016 | 424 | 0.510 |
Why?
|
| Polyamines | 1 | 2017 | 11 | 0.510 |
Why?
|
| Peroxides | 1 | 2017 | 32 | 0.510 |
Why?
|
| Rats, Inbred F344 | 4 | 2019 | 134 | 0.500 |
Why?
|
| Rats | 14 | 2017 | 1610 | 0.500 |
Why?
|
| Graft Survival | 2 | 2017 | 313 | 0.490 |
Why?
|
| Extracellular Matrix | 4 | 2020 | 243 | 0.480 |
Why?
|
| Oxidative Stress | 3 | 2006 | 243 | 0.450 |
Why?
|
| Glutathione | 3 | 2006 | 45 | 0.450 |
Why?
|
| Cells, Cultured | 6 | 2019 | 821 | 0.430 |
Why?
|
| Immunocompetence | 1 | 2014 | 11 | 0.430 |
Why?
|
| Female Urogenital Diseases | 1 | 2013 | 4 | 0.410 |
Why?
|
| Urogenital System | 1 | 2013 | 9 | 0.410 |
Why?
|
| Insulin | 5 | 2017 | 369 | 0.410 |
Why?
|
| Gonadotropins | 1 | 2012 | 3 | 0.390 |
Why?
|
| Biopolymers | 1 | 2013 | 4 | 0.390 |
Why?
|
| Peptide Hormones | 1 | 2012 | 10 | 0.390 |
Why?
|
| Artificial Organs | 1 | 2013 | 13 | 0.380 |
Why?
|
| Steroids | 1 | 2012 | 34 | 0.380 |
Why?
|
| Blood Glucose | 5 | 2017 | 495 | 0.350 |
Why?
|
| Epithelial Cells | 3 | 2017 | 129 | 0.330 |
Why?
|
| Particle Size | 5 | 2017 | 47 | 0.330 |
Why?
|
| Gels | 2 | 2006 | 32 | 0.310 |
Why?
|
| Lipid Peroxides | 3 | 2004 | 8 | 0.300 |
Why?
|
| Micronutrients | 2 | 2006 | 20 | 0.300 |
Why?
|
| Mice | 7 | 2017 | 2529 | 0.300 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2005 | 19 | 0.280 |
Why?
|
| Uterus | 2 | 2019 | 79 | 0.280 |
Why?
|
| Drug Carriers | 3 | 2019 | 24 | 0.270 |
Why?
|
| Cell Differentiation | 4 | 2017 | 469 | 0.260 |
Why?
|
| Gastrointestinal Tract | 3 | 2012 | 31 | 0.260 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2017 | 754 | 0.260 |
Why?
|
| Delayed-Action Preparations | 5 | 2017 | 36 | 0.260 |
Why?
|
| Rats, Inbred Lew | 6 | 2016 | 120 | 0.250 |
Why?
|
| Viscosity | 3 | 2017 | 23 | 0.250 |
Why?
|
| Trans-Activators | 2 | 2017 | 42 | 0.250 |
Why?
|
| Gastric Emptying | 2 | 2005 | 4 | 0.250 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 52 | 0.250 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2020 | 69 | 0.250 |
Why?
|
| Amnion | 2 | 2017 | 37 | 0.240 |
Why?
|
| Dietary Supplements | 2 | 2006 | 187 | 0.240 |
Why?
|
| Swine | 4 | 2017 | 216 | 0.240 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2006 | 29 | 0.240 |
Why?
|
| Female | 10 | 2019 | 20375 | 0.230 |
Why?
|
| Stem Cells | 3 | 2020 | 314 | 0.230 |
Why?
|
| Indomethacin | 1 | 2005 | 6 | 0.220 |
Why?
|
| Stomach Diseases | 1 | 2005 | 7 | 0.220 |
Why?
|
| Proton Pump Inhibitors | 1 | 2004 | 11 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 69 | 0.210 |
Why?
|
| Povidone | 1 | 2004 | 1 | 0.210 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2014 | 14 | 0.210 |
Why?
|
| Cryoprotective Agents | 1 | 2004 | 10 | 0.210 |
Why?
|
| Postural Balance | 1 | 2016 | 180 | 0.210 |
Why?
|
| Glycemic Index | 1 | 2004 | 14 | 0.210 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 163 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 196 | 0.200 |
Why?
|
| Cryopreservation | 1 | 2004 | 57 | 0.200 |
Why?
|
| Denervation | 1 | 2003 | 12 | 0.200 |
Why?
|
| Occupational Exposure | 1 | 2016 | 231 | 0.200 |
Why?
|
| Intestine, Small | 1 | 2003 | 40 | 0.200 |
Why?
|
| Omeprazole | 1 | 2002 | 1 | 0.190 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 240 | 0.190 |
Why?
|
| Gastric Mucosa | 1 | 2002 | 13 | 0.190 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 21 | 0.190 |
Why?
|
| Transients and Migrants | 1 | 2016 | 298 | 0.190 |
Why?
|
| Time Factors | 5 | 2014 | 2195 | 0.180 |
Why?
|
| Organ Transplantation | 2 | 2012 | 66 | 0.170 |
Why?
|
| Proteome | 1 | 2020 | 41 | 0.160 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2020 | 4 | 0.160 |
Why?
|
| Adhesives | 1 | 2020 | 7 | 0.160 |
Why?
|
| Excipients | 1 | 2020 | 2 | 0.160 |
Why?
|
| Polymethyl Methacrylate | 1 | 2020 | 12 | 0.160 |
Why?
|
| Hispanic Americans | 1 | 2016 | 930 | 0.160 |
Why?
|
| Cell Proliferation | 3 | 2016 | 604 | 0.150 |
Why?
|
| Aromatase | 1 | 2019 | 12 | 0.150 |
Why?
|
| Luteinizing Hormone | 1 | 2019 | 15 | 0.150 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2019 | 28 | 0.150 |
Why?
|
| Microscopy, Confocal | 2 | 2017 | 71 | 0.150 |
Why?
|
| Progesterone | 1 | 2019 | 69 | 0.150 |
Why?
|
| Ovariectomy | 1 | 2019 | 162 | 0.150 |
Why?
|
| Male | 9 | 2018 | 19754 | 0.140 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2018 | 1 | 0.140 |
Why?
|
| Strontium | 1 | 2017 | 5 | 0.140 |
Why?
|
| Pancreas Transplantation | 2 | 2017 | 247 | 0.140 |
Why?
|
| Osteocalcin | 1 | 2017 | 9 | 0.140 |
Why?
|
| Rats, Wistar | 2 | 2016 | 79 | 0.140 |
Why?
|
| Hormones | 1 | 2017 | 20 | 0.140 |
Why?
|
| Activins | 1 | 2017 | 3 | 0.130 |
Why?
|
| Niacinamide | 1 | 2017 | 8 | 0.130 |
Why?
|
| Muscle Development | 1 | 2017 | 49 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 83 | 0.130 |
Why?
|
| Permeability | 1 | 2017 | 10 | 0.130 |
Why?
|
| Cations | 1 | 2017 | 10 | 0.130 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2017 | 66 | 0.130 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2016 | 10 | 0.130 |
Why?
|
| Compressive Strength | 1 | 2017 | 22 | 0.130 |
Why?
|
| Thyroxine | 1 | 2016 | 16 | 0.130 |
Why?
|
| Pancreatectomy | 1 | 2017 | 25 | 0.130 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 43 | 0.130 |
Why?
|
| Hypothyroidism | 1 | 2016 | 12 | 0.130 |
Why?
|
| Thyroid Gland | 1 | 2016 | 15 | 0.130 |
Why?
|
| Urethra | 1 | 2017 | 100 | 0.120 |
Why?
|
| Foreign Bodies | 1 | 2016 | 30 | 0.120 |
Why?
|
| Bacteria | 1 | 2017 | 55 | 0.120 |
Why?
|
| Awards and Prizes | 1 | 2016 | 13 | 0.120 |
Why?
|
| Glucose | 3 | 2018 | 188 | 0.120 |
Why?
|
| Epidermal Growth Factor | 1 | 2016 | 21 | 0.120 |
Why?
|
| Bone Density | 1 | 2017 | 203 | 0.120 |
Why?
|
| Models, Biological | 2 | 2016 | 392 | 0.120 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 34 | 0.120 |
Why?
|
| Flow Cytometry | 2 | 2013 | 186 | 0.120 |
Why?
|
| Calcium | 1 | 2017 | 323 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2016 | 61 | 0.120 |
Why?
|
| History, 20th Century | 1 | 2016 | 73 | 0.120 |
Why?
|
| Lipid Peroxidation | 2 | 2006 | 32 | 0.120 |
Why?
|
| Organoids | 1 | 2016 | 98 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 1477 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 225 | 0.110 |
Why?
|
| Recovery of Function | 1 | 2016 | 205 | 0.110 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 183 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 241 | 0.110 |
Why?
|
| Angiogenic Proteins | 2 | 2010 | 10 | 0.100 |
Why?
|
| Mice, Inbred Strains | 2 | 2004 | 46 | 0.100 |
Why?
|
| Cell Communication | 1 | 2013 | 29 | 0.100 |
Why?
|
| Urodynamics | 1 | 2013 | 36 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2013 | 67 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2013 | 72 | 0.100 |
Why?
|
| Endocrine Cells | 1 | 2012 | 3 | 0.100 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 82 | 0.100 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2012 | 13 | 0.090 |
Why?
|
| Blood Vessels | 2 | 2010 | 51 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2013 | 89 | 0.090 |
Why?
|
| Urine | 1 | 2012 | 65 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 98 | 0.090 |
Why?
|
| Immunosuppression | 1 | 2012 | 120 | 0.090 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 107 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2013 | 241 | 0.090 |
Why?
|
| General Surgery | 1 | 2012 | 86 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2010 | 97 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2010 | 30 | 0.080 |
Why?
|
| Materials Testing | 2 | 2010 | 92 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2010 | 138 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 497 | 0.080 |
Why?
|
| Neoplasms | 1 | 2017 | 762 | 0.080 |
Why?
|
| Capillaries | 1 | 2009 | 23 | 0.080 |
Why?
|
| Cytokines | 1 | 2010 | 247 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 476 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2016 | 3460 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2010 | 351 | 0.060 |
Why?
|
| Actins | 3 | 2013 | 51 | 0.060 |
Why?
|
| Models, Animal | 2 | 2009 | 173 | 0.060 |
Why?
|
| Liver Transplantation | 3 | 2012 | 183 | 0.060 |
Why?
|
| X-Ray Microtomography | 2 | 2016 | 41 | 0.060 |
Why?
|
| Trace Elements | 1 | 2006 | 7 | 0.060 |
Why?
|
| Flavonoids | 1 | 2006 | 19 | 0.060 |
Why?
|
| Phenols | 1 | 2006 | 18 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2006 | 41 | 0.060 |
Why?
|
| Porosity | 1 | 2005 | 39 | 0.060 |
Why?
|
| Elasticity | 1 | 2005 | 38 | 0.060 |
Why?
|
| Tensile Strength | 1 | 2005 | 56 | 0.060 |
Why?
|
| Vitamins | 1 | 2006 | 73 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 165 | 0.060 |
Why?
|
| Mice, Inbred A | 1 | 2005 | 4 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 1015 | 0.060 |
Why?
|
| Peroxidase | 1 | 2005 | 28 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2004 | 43 | 0.050 |
Why?
|
| Equipment Design | 2 | 2017 | 179 | 0.050 |
Why?
|
| Fatty Liver | 1 | 2004 | 66 | 0.050 |
Why?
|
| Pharmaceutic Aids | 1 | 2004 | 1 | 0.050 |
Why?
|
| Glycerol | 1 | 2004 | 6 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2004 | 19 | 0.050 |
Why?
|
| Nitrogen | 1 | 2004 | 10 | 0.050 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2004 | 13 | 0.050 |
Why?
|
| Temperature | 1 | 2004 | 51 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2016 | 880 | 0.050 |
Why?
|
| Rats, Inbred ACI | 1 | 2003 | 5 | 0.050 |
Why?
|
| Ileum | 1 | 2003 | 16 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 622 | 0.050 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2002 | 3 | 0.050 |
Why?
|
| Receptors, Prolactin | 1 | 2002 | 1 | 0.050 |
Why?
|
| Regeneration | 2 | 2016 | 170 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1550 | 0.040 |
Why?
|
| Solubility | 1 | 2020 | 38 | 0.040 |
Why?
|
| Endothelial Cells | 2 | 2013 | 197 | 0.040 |
Why?
|
| Diffusion | 1 | 2019 | 14 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 189 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 269 | 0.040 |
Why?
|
| Cell Death | 1 | 2018 | 71 | 0.030 |
Why?
|
| Dogs | 1 | 2018 | 120 | 0.030 |
Why?
|
| Adult | 2 | 2016 | 9586 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2017 | 25 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2012 | 413 | 0.030 |
Why?
|
| Rats, Inbred WF | 1 | 2016 | 8 | 0.030 |
Why?
|
| Organogenesis | 1 | 2016 | 18 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 48 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 43 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 69 | 0.030 |
Why?
|
| Macrophages | 1 | 2016 | 195 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 644 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2013 | 6 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2013 | 14 | 0.030 |
Why?
|
| Oxidopamine | 1 | 2013 | 9 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 32 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 2013 | 12 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2013 | 47 | 0.030 |
Why?
|
| Cadherins | 1 | 2013 | 27 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2017 | 689 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 160 | 0.020 |
Why?
|
| Detergents | 1 | 2013 | 16 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 152 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2013 | 47 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 62 | 0.020 |
Why?
|
| Perfusion | 1 | 2013 | 74 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 537 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 72 | 0.020 |
Why?
|
| Nanocapsules | 1 | 2012 | 4 | 0.020 |
Why?
|
| Calcium Chloride | 1 | 2012 | 2 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 10637 | 0.020 |
Why?
|
| Larynx | 1 | 2012 | 19 | 0.020 |
Why?
|
| Chondroitin Sulfates | 1 | 2012 | 21 | 0.020 |
Why?
|
| Skin, Artificial | 1 | 2012 | 33 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2012 | 35 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2012 | 74 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 12203 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2012 | 84 | 0.020 |
Why?
|
| Collagen | 1 | 2012 | 220 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 146 | 0.020 |
Why?
|
| Wound Healing | 1 | 2012 | 188 | 0.020 |
Why?
|
| Corneal Transplantation | 1 | 2010 | 14 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 2010 | 29 | 0.020 |
Why?
|
| Transplants | 1 | 2010 | 23 | 0.020 |
Why?
|
| Intestines | 1 | 2010 | 60 | 0.020 |
Why?
|
| Trachea | 1 | 2010 | 52 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 245 | 0.020 |
Why?
|
| Heart | 1 | 2010 | 185 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2009 | 10 | 0.020 |
Why?
|
| Liver | 1 | 2010 | 492 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 543 | 0.020 |
Why?
|
| Kidney | 1 | 2010 | 523 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2010 | 512 | 0.020 |
Why?
|
| Heart Failure | 1 | 2012 | 761 | 0.010 |
Why?
|
| Placental Lactogen | 1 | 2002 | 1 | 0.010 |
Why?
|
| Tissue Fixation | 1 | 2002 | 10 | 0.010 |
Why?
|
| Cell Size | 1 | 2002 | 36 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 47 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2002 | 125 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2002 | 458 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2002 | 500 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 790 | 0.010 |
Why?
|